SSRI: Clinical Trials

36 trials of SSRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 4 unknown, 2 recruiting, 2 withdrawn. 10 Phase 4, 7 Not applicable, 7 Phase 3, 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Not applicable7Completed 5, Unknown 2
Phase 37Completed 7
Phase 14Completed 4
Phase 23Completed 2, Active not recruiting 1

Follow SSRI: new trials by email Literature Review of SSRI trials Research Report on SSRI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
Use of magnesium with SSRI, SSRI - Major Depressive Diorder
Phase 2Active not recruitingUniversity of Child Health Sciences and Children's Hospital, Lahore502025-12-012026-03-09
Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
Virtual Reality Exposure Therapy, Sertraline (Oral Antidepressant) - Social Anxiety Disorder
Phase 4RecruitingEmine Kanmaz562024-11-152025-09-25
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Vortioxetine Tablet, SSRI - Major Depressive Disorder
CompletedTakeda1477772024-06-012025-03-03
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
SSRI - Depression, Inflammation
CompletedGermans Trias i Pujol Hospital502024-04-012026-09-14
Detoxification From the Lipid Tract
electroencephalogram biofeedback, electrical brain stimulation, ultra-low frequency transcranial magnetic stimulation - COVID-19 Vaccine Adverse Reaction
Phase 4CompletedPachankis, Yang I., M.D.12024-02-262024-04-10
Non-invasive BCI and Application Verification for Depressed People
SSRI, rTMS, Neuro-Feedback - Depression, Major Depressive Disorder
Phase 4RecruitingShanghai Mental Health Center4002023-07-012024-05-16
Psychiatric Orders in Psychoanalytic Treatment of ASD
Psychoanalysis, sertraline 50mg, Duloxetine 20 MG - PTSD, Autism Spectrum Disorder High-Functioning
UnknownYang I. Pachankis, PhD12023-06-012023-07-05
Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder
SSRI, SIA, AIA - Major Depressive Disorder
Not applicableUnknownXiaomei Shao1202022-11-012023-04-27
The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder
SSRI, SIA, AIA - Major Depressive Disorder
Not applicableCompletedXiaomei Shao1202022-11-012024-02-20
SSRI's and the Rate of Progression From MCI to Dementia
SSRI - Mild Cognitive Impairment, Dementia
WithdrawnOhio State University2021-09-012023-10-11
A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women
Sertraline, Interpersonal therapy - Perinatal Depression, HIV-1-infection
Phase 4CompletedUniversity of North Carolina, Chapel Hill802019-10-302021-11-10
Stepped Care AiTBS 2 Depression Study (Ghent)
aiTBS, CCT, SSRI - Depressive Disorder, Major, Treatment Resistant Depression
Not applicableCompletedUniversity Hospital, Ghent682017-10-052024-09-19
Cognitive Processing Therapy vs. Sertraline for the Treatment of PTSD & SUD in Egyptian Patients
Cognitive processing therapy, Sertraline, Placebo Control - Psychologic Manipulation
Phase 1CompletedBritish University In Egypt1502016-01-012021-04-01
Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
selective serotonin reuptake inhibitor - Local Anesthesia
CompletedIsfahan University of Medical Sciences902015-06-012019-02-15
Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder
Vortioxetine 10-20 mg, Placebo, SSRI - Major Depressive Disorder
Phase 3CompletedH. Lundbeck A/S1512014-10-012017-05-24
The ISLAND Study: InSuLa Assessed Needs for Depression
Selective serotonin re-uptake inhibitor, Cognitive Behavioral Therapy, Combination treatment (SSRI + CBT) - Depression
Phase 4CompletedEmory University772014-09-012020-11-05
CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
Cognitive behavioral therapy, SSRI - Depression, Epilepsy, Temporal Lobe
Not applicableCompletedEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez152014-08-012015-03-30
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
Sertraline, Cognitive Behavioural Therapy - Generalised Anxiety Disorder
Phase 4TerminatedUniversity College, London52014-08-012016-07-11
Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin
tDCS, Citalopram, sham-tDCS + placebo - Healthy Young and Older Adults
Phase 1CompletedCharite University, Berlin, Germany402014-04-012021-05-12
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
SSRI, CBT - Internalizing Psychopathologies (IPs) Depression and Anxiety
Phase 4CompletedUniversity of Illinois at Chicago2712013-12-132018-10-11

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Depressive Disorder, Major (17)  ·  Depression (10)  ·  Anxiety Disorders (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Depressive Disorder (2)  ·  Phobia, Social (2)  ·  Stroke (2)  ·  Adjustment Disorders (1)  ·  Alzheimer Disease (1)  ·  Bipolar Disorder (1)  ·  Borderline Personality Disorder (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Epilepsy (1)

Sponsors

Eli Lilly and Company (6)  ·  University of Aarhus (2)  ·  Xiaomei Shao (2)  ·  Baker Heart Research Institute (1)  ·  British University In Egypt (1)  ·  Charite University, Berlin, Germany (1)  ·  El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez (1)  ·  Emine Kanmaz (1)  ·  Emory University (1)  ·  Germans Trias i Pujol Hospital (1)  ·  H. Lundbeck A/S (1)  ·  Hadassah Medical Organization (1)  ·  Hoffmann-La Roche (1)  ·  Inje University (1)  ·  Isfahan University of Medical Sciences (1)

Countries

United States (12)  ·  China (6)  ·  Germany (4)  ·  Japan (4)  ·  Belgium (3)  ·  Mexico (3)  ·  Slovakia (3)  ·  Spain (3)  ·  Australia (2)  ·  Croatia (2)  ·  Denmark (2)  ·  Finland (2)  ·  Puerto Rico (2)  ·  Russia (2)  ·  South Korea (2)

Top investigators

Xiaomei Shao, Ph.D (2)  ·  Amani Elbarazi, Ph.D. (1)  ·  Arieh Y Shalev, M.D. (1)  ·  Atif Najum, MBBS, FCPS (1)  ·  Boadie W Dunlop, MD/MS (1)  ·  Boris Modrau, M.D. (1)  ·  Chris Baeken, Prof. (1)  ·  Daniel Crail-Melendez, MD (1)  ·  Elizabeth Stringer, MD (1)

Results publications

PMID 27035159, PMID 27685842, PMID 16585452, PMID 21724790, PMID 21969418, PMID 22945620, PMID 24643964, PMID 25894953, PMID 26376447, PMID 27135249, PMID 27555381, PMID 29894598, PMID 30355209, PMID 31060042, PMID 32122334, PMID 33860531, PMID 33896622, PMID 34274600, PMID 35141873, PMID 35267254, PMID 35803896, PMID 36997260, PMID 37255689, PMID 37641586, PMID 38767196, PMID 41449680, PMID 42286600

NIH funding

2014 (1), R01MH073719 (1), R01MH074807 (1), R01MH101497 (1), R21MH115806 (1)